- Home
- RCKY vs TRDA Comparison
RCKY vs TRDA Comparison
Compare RCKY & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- TRDA
- Stock Information
- Founded
- RCKY 1932
- TRDA 2016
- Country
- RCKY United States
- TRDA United States
- Employees
- RCKY N/A
- TRDA N/A
- Industry
- RCKY Shoe Manufacturing
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- TRDA Health Care
- Exchange
- RCKY Nasdaq
- TRDA Nasdaq
- Market Cap
- RCKY 196.3M
- TRDA 233.5M
- IPO Year
- RCKY 1993
- TRDA 2021
- Fundamental
- Price
- RCKY $30.55
- TRDA $5.64
- Analyst Decision
- RCKY Buy
- TRDA Strong Buy
- Analyst Count
- RCKY 1
- TRDA 3
- Target Price
- RCKY $40.00
- TRDA $25.67
- AVG Volume (30 Days)
- RCKY 54.6K
- TRDA 215.2K
- Earning Date
- RCKY 10-29-2025
- TRDA 11-04-2025
- Dividend Yield
- RCKY 2.08%
- TRDA N/A
- EPS Growth
- RCKY 24.23
- TRDA N/A
- EPS
- RCKY 2.48
- TRDA N/A
- Revenue
- RCKY $462,328,000.00
- TRDA $79,476,000.00
- Revenue This Year
- RCKY $7.02
- TRDA N/A
- Revenue Next Year
- RCKY $3.96
- TRDA N/A
- P/E Ratio
- RCKY $12.05
- TRDA N/A
- Revenue Growth
- RCKY N/A
- TRDA N/A
- 52 Week Low
- RCKY $11.93
- TRDA $4.93
- 52 Week High
- RCKY $33.04
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- RCKY 62.59
- TRDA 54.00
- Support Level
- RCKY $28.64
- TRDA $5.08
- Resistance Level
- RCKY $29.69
- TRDA $5.49
- Average True Range (ATR)
- RCKY 0.96
- TRDA 0.30
- MACD
- RCKY -0.10
- TRDA 0.04
- Stochastic Oscillator
- RCKY 97.09
- TRDA 83.67
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.